Cervical Spondylotic Radiculopathy (CSR)
Conditions
Interventions
Healthy Subjects:Traction Manipulation Performed in Sitting and Supine Positions
CSR patients:Traction Manipulation Performed in Sitting and Supine Positions
Sponsors
Guangdong Provincial Hospital of Chinese Medicine - University Town Orthopedics Department
Eligibility
Sex/Gender
All
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria for Healthy Subjects: a. No prior diagnosis of cervical spondylosis or other spinal disorders. b. Aged between 30 and 50 years. c. Evaluated by an experienced spine specialist to rule out cervical spondylosis, scapulodynia, related disorders, and other spinal conditions. d. Ability to understand and voluntarily sign the informed consent form. Inclusion Criteria for Patients with Cervical Spondylotic Radiculopathy (CSR): a. Meeting the diagnostic criteria for CSR, with reference to the 2015 Chinese Expert Consensus on the Standardized Diagnosis and Management of Cervical Spondylotic Radiculopathy and the 2011 North American Spine Society clinical guideline "An evidence-based clinical guideline for the diagnosis and treatment of cervical radiculopathy from degenerative disorders." b. Presence of radicular pain caused by single-segment disc herniation at C5/6. c. Aged between 30 and 50 years. d. Ability to understand and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion Criteria for Healthy Subjects: a. Patients with severe primary diseases of the hepatic, renal, or hematopoietic systems, as well as those with malignancies. b. Disabilities that may impede the ability to participate in the clinical trial (e.g., blindness, deafness, mutism, intellectual impairment, or psychiatric disorders). c. Women who are pregnant, planning pregnancy, or lactating. d. Subjects deemed by the investigator to be unsuitable for participation in the study. Exclusion Criteria for Patients with Cervical Spondylotic Radiculopathy (CSR): a. Presence of cervical disc herniation at spinal levels other than C5/6. b. Coexisting conditions such as ossification of the posterior longitudinal ligament, congenital spinal anomalies (e.g., scoliosis, deformities), or a history of previous cervical spine trauma or surgery. c. Comorbid orthopedic conditions including bone and joint tuberculosis, infections, or severe senile osteoporosis. d. Disorders that may cause symptoms mimicking or confounding those of CSR, such as myofascitis of the neck and shoulder, periarthritis of the shoulder, thoracic outlet syndrome, progressive muscular atrophy, ulnar neuritis, lateral epicondylitis, carpal tunnel syndrome, or angina pectoris. e. Patients with severe primary diseases of the hepatic, renal, or hematopoietic systems, as well as those with malignancies. f. Disabilities that may impede the ability to participate in the clinical trial (e.g., blindness, deafness, mutism, intellectual impairment, or psychiatric disorders). g. Women who are pregnant, planning pregnancy, or lactating. h. Patients deemed by the investigator to be unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Integrated Electromyography;Root Mean Square;Mean Absolute Value;Mean Power Frequency;Median Frequency;arm pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| neck pain;Self-Assessment of Global Neck Change;Cervical Vertebral Range of Motion;deep neck flexor endurance;cervical spine function; | — |
Countries
China
Contacts
Public ContactChen Shudong
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed